British Columbia Investment Management Corporation »

Vaneck Vectors Pharmaceutical etf shares owned by British Columbia Investment Management Corporation

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by British Columbia Investment Management Corporation from 13F filings

Historical chart of British Columbia Investment Management Corporation investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by British Columbia Investment Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by British Columbia Investment Management Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $71M 689k 103.17

More positions owned by British Columbia Investment Management Corporation

NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Broad Usd High (USHY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Rbc Cad (RY)
Shopify Cl A Sub Vtg Shs (SHOP)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Toronto Dominion Bk Ont Com New (TD)
Tesla Motors (TSLA)
Waste Connections (WCN)

View all positions for British Columbia Investment Management Corporation

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Clal Insurance Enterprises Holdings
Bnp Paribas Arbitrage, Snc
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Jane Street
Miller Investment Management
Adamsbrown Wealth Consultants
UBS Group
LPL Financial

View all funds holding Vaneck Vectors Pharmaceutical etf